Page 166 - 2019秋季手冊內頁-ebook測試

Liu JH, Liao XW, Chen CH, Yao M, Li CC, Lin CT, Tsai CH, Chou WC, Hou HA, Huang SY, Tien HF, Tang JL,
Ko BS (corresponding). Br. J Haematol. 2019 Jul;186(1):72-85.
3. A BLSTM with attention network for predicting acute myeloid leukemia patient's prognosis using
comprehensive clinical parameters
Lu CC, Li JL, Wang YF, Ko BS, Tang JL, Lee CC. Conf Proc IEEE Eng Med Biol Soc. 2019 Jul;2019:2455- 2458.
4. Learning a cytometric deep phenotype embedding for automatic hematological malignancies classification
Li JL, Wang YF, Ko BS, Li CC, Tang JL, Lee CC. Conf Proc IEEE Eng Med Biol Soc. 2019 Jul;2019:1733-1736.
5. ZNF479 downregulates metallothionein-1 expression by regulating ASH2L and DNMT1 in hepatocellular
carcinoma.
Wu YJ, Ko BS (co‐1st author), Liang SM, Lu YJ, Jan YJ, Jiang SS, Shyue SK, Chen L, Liou JY. Cell Death Dis. 2019 May 28;10(6):408.
6. Immediate knowledge improvement and long-term teaching confidence after general medicine faculty training program.
Tseng FY, Lin LC, Ko BS, Chu TS, Tsai SL, Sheng WH, Yen CJ, Chang CH, Wu CH, Shih SR, Chiu WY, Pan SC, Chen WP, Chang PY. J Formos Med Assoc. 2019 Aug 16. pii: S0929-6646(19)30238-4.
7. Long-term safety and efficacy of deferasirox in patients with myelodysplastic syndrome, aplastic anemia and other rare anemia in Taiwan
Ko BS, Chang MC, Chiou TJ, Chang TK, Chen YC, Lin SF, Chang CS, Lu YC, Yeh SP, Chen TY, Hwang WS. Hematology. 2019 Dec;24(1):247-254.
8. Clinically validated machine learning algorithm for detecting residual diseases with multicolor flow cytometry analysis in acute myeloid leukemia and myelodysplastic syndrome.
Ko BS, Wang YF, Li JJ, Li CC, Weng PF, Hsu SC, Hou HA, Huang HH, Yao M, Lin CT, Liu CH, Tsai CH, Huang TC, Wu SJ, Huang SY, Chou WC, Tien FM, Lee CC, Tang JL. EBioMedicine 2018 Nov;37:91-100.
9. Subtype-specific epidemiology of lymphoid malignancies in Taiwan compared to Japan and the United States, 2002-2012.
Ko BS, Chen LR, Huang HH, Chen HM, Hsiao FY. Cancer Med. 2018 Nov;7(11):5820-5831.
10. Rituximab maintenance improves overall survival in follicular lymphoma: A retrospective nationwide real-world analysis from Taiwan Cancer Registry Database.
Huang HH, Wen YC, Chen HM, Hsiao FY, Ko BS (corresponding). Cancer Med. 2018 Aug;7(8):3582-3591.
11. Women with diffuse large B cell lymphoma benefit more from rituximab-containing chemotherapy. Huang HH, Hsiao FY, Chen LJ, Chen HM, Ko BS (corresponding). J Womens Health (Larchmt). 2018 Aug;7(8):3582-3591.
12. Prognostic significance of 14-3-3ε, aldo-keto reductase family 1 B10 and metallothionein-1 in hepatocellular carcinoma.
Wu CY, Jan YJ, Ko BS (co‐1st author), Wu YJ, Wu YJ, Liou JY. Anticancer Res. 2018 Dec;38(12):6855-6863.
13. GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia.
Tien FM, Hou HA, Tsai CH, Tang JL, Chiu YC, Chen CY, Kuo YY, Tseng MH, Peng YL, Liu MC, Liu CW, Liao XW, Lin LI, Lin CT, Wu SJ, Ko BS, Hsu SC, Huang SY, Yao M, Chou WC, Tien HF. Blood Cancer J. 2018 Aug 31;8(9):87
14. Repurposing nilotinib for cytomegalovirus infection prophylaxis after allogeneic hematopoietic stem cell transplantation: A single-arm, phase II trial.
Lin CT, Hsueh PR, Wu SJ, Yao M, Ko BS, Li CC, Hsu CA, Tang JL, Tien HF. Biol Blood Marrow Transplant. 2018 Nov;24(11):2310-2315.
15. 2016 guideline strategies for the use of antifungal agents in patients with hematological malignancies or hematopoietic stem cell transplantation recipients in Taiwan.
Ko BS, Chen WT, Kung HC, Wu UI, Tang JL, Yao M, Chen YC, Tien HF, Chang SC, Chuang YC, Lin DT; Infectious Diseases Society of Taiwan; Hematology Society of Taiwan; Taiwan Society of Blood and Marrow Transplantation; Medical Foundation in Memory of Dr Deh-Lin Cheng; Foundation of Professor Wei-Chuan Hsieh for Infectious Diseases Research and Education; CY Lee's Research Foundation for Pediatric Infectious Diseases and Vaccines. J Microbiol Immunol Infect. 2018 Jun;51(3):287-301
167